Status:

TERMINATED

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Lead Sponsor:

Allergan

Conditions:

Premature Ejaculation

Eligibility:

MALE

18-50 years

Phase:

PHASE2

Brief Summary

This is a safety and efficacy study of OnabotulinumtoxinA for the treatment of premature ejaculation (PE) in male participants.

Detailed Description

This is a phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-escalation study to assess a range of doses of OnabotulinumtoxinA for the treatment of male participants with PE. Par...

Eligibility Criteria

Inclusion

  • History of premature ejaculation
  • Stable monogamous sexual relationship with female partner for at least 6 months, and intends to continue with the same partner for the duration of the study
  • Participant has ability to follow study instructions and complete study assessment tools

Exclusion

  • Premature ejaculation caused by medical or surgical issues, or is related to stress or other issues (eg, relationship problems)
  • Pain with ejaculation
  • Planned use of topical penile treatments (eg, anesthetics, herbal treatments) or penile injections during the study
  • Prior genital, prostatic or lower urinary tract surgery (other than vasectomy or circumcision)
  • Previous or current usage of botulinum toxin therapy of any serotype for any urological condition
  • Use of botulinum toxin therapy of any serotype for any nonurological condition (eg, cosmetic, chronic migraine) during the 12 weeks prior to screening, or planned usage during the study
  • Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis

Key Trial Info

Start Date :

August 7 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 15 2017

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT01917006

Start Date

August 7 2013

End Date

August 15 2017

Last Update

October 18 2018

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

San Diego Sexual Medicine

San Diego, California, United States, 92120

2

LA Biomedical Research Institute at Harbor-UCLA Medical Center

Torrance, California, United States, 90502

3

Connecticut Clinical Research Center

Middlebury, Connecticut, United States, 06762

4

Center for Marital and Sexual Health of South Florida

West Palm Beach, Florida, United States, 33401

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation | DecenTrialz